← FDA Drug Approvals (Drugs@FDA)

ARYMO ER

NDA · New Drug Application · Sponsor: ZYLA · Approved 2017-01-09

Drug application

FDA Application #

NDA208603

Application type

New Drug Application

Brand name

ARYMO ER

Generic name

Morphine Sulfate

Active ingredients

MORPHINE SULFATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYLA

First approval

2017-01-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown